LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Group 1 - LENZ Therapeutics recently received approval for a therapy targeting presbyopia, a condition affecting near vision in older adults [3] - Eef Schimmelpennink, President and CEO of LENZ Therapeutics, participated in a Q&A session to provide insights into the company's developments and history [3]